Frontiers in Immunology | Cancer Immunity and Immunotherapy

Original Research

Published on 30 Apr 2024

Adverse events associated with immune checkpoint inhibitors in non-small cell lung cancer: a safety analysis of clinical trials and FDA pharmacovigilance system

in Cancer Immunity and Immunotherapy

Xueyan Liang
Hewei Xiao
Huijuan Li
Xiaoyu Chen
Yan Li

Frontiers in Immunology

doi 10.3389/fimmu.2024.1396752

6,523 views
3 citations

Original Research

Published on 30 Apr 2024

Baseline immunoglobulin G and immune function in non-Hodgkin lymphoma: a retrospective analysis

in Cancer Immunity and Immunotherapy

Danielle Brazel
Christopher Grant
Angelo Cabal
Wen-Pin Chen
Lauren Pinter-Brown

Frontiers in Immunology

doi 10.3389/fimmu.2024.1334899

3,267 views
3 citations

Review

Published on 30 Apr 2024

Circulating tumor DNA: from discovery to clinical application in breast cancer

in Cancer Immunity and Immunotherapy

Jiachi Xu
Hongyu Gao
Xinyu Guan
Jiahao Meng
Shirong Ding
Qian Long
Wenjun Yi

Frontiers in Immunology

doi 10.3389/fimmu.2024.1355887

5,898 views
10 citations

Editorial

Published on 30 Apr 2024

Editorial: Comprehensive profiling cancer immunity with multimodal approaches for clinical management

in Cancer Immunity and Immunotherapy

Geng Chen
Yi Shi
Wenming Xiao
David P. Kreil

Frontiers in Immunology

doi 10.3389/fimmu.2024.1421576

1,067 views

Original Research

Published on 30 Apr 2024

PD-L1 targeted peptide demonstrates potent antitumor and immunomodulatory activity in cancer immunotherapy

in Cancer Immunity and Immunotherapy

Yulai Liang
Huazao Luo
Xue Li
Shuang Liu
Arslan Habib
Baoxiu Liu
Jiansheng Huang
Jingbo Wang
Han Yi
Bo Hu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1367040

3,670 views
2 citations

Case Report

Published on 30 Apr 2024

Case report: Preventive infusion of donor-derived CD7 chimeric antigen receptor T cells after allogeneic hematopoietic stem cell transplantation

in Cancer Immunity and Immunotherapy

Ying Jiang
Dan Feng
Jun Zhu
Daolin Wei
Chuxian Zhao
Huixia Liu
Shan Shao
Chun Wang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1381308

1,610 views
2 citations

Original Research

Published on 30 Apr 2024

Designer umbilical cord-stem cells induce alveolar wall regeneration in pulmonary disease models

in Cancer Immunity and Immunotherapy

Mayumi Iwatake
Tokiko Nagamura-Inoue
Ryoichiro Doi
Yukinori Tanoue
Mitsutoshi Ishii
Hiroshi Yukawa
Keitaro Matsumoto
Koichi Tomoshige
Takeshi Nagayasu
Tomoshi Tsuchiya

Frontiers in Immunology

doi 10.3389/fimmu.2024.1384718

4,085 views
2 citations

Correction

Published on 29 Apr 2024

Corrigendum: Immunoglobulins and serum proteins impair anti-tumor NK cell effector functions in malignant ascites

in Cancer Immunity and Immunotherapy

Antonio Hrvat
Sonja Benders
Rainer Kimmig
Sven Brandau
Nina Mallmann-Gottschalk

Frontiers in Immunology

doi 10.3389/fimmu.2024.1420991

881 views

Methods

Published on 29 Apr 2024

Coupling imaging mass cytometry with Alcian blue histochemical staining for a single-slide approach

in Cancer Immunity and Immunotherapy

Patrice Hemon
Danivanh Ben-Guigui
Margaux Geier
Marine Castillon
Corentin Paranthoen
Jacques-Olivier Pers
Marion Le Rochais
Arnaud Uguen

Frontiers in Immunology

doi 10.3389/fimmu.2024.1379154

1,765 views

Original Research

Published on 29 Apr 2024

Identification of PANoptosis-related subtypes, construction of a prognosis signature, and tumor microenvironment landscape of hepatocellular carcinoma using bioinformatic analysis and experimental verification

in Cancer Immunity and Immunotherapy

Guoqing Ouyang
Qiuyun Li
Yangnian Wei
Wenbin Dai
Haojian Deng
Youli Liu
Jiaguang Li
Mingjuan Li
Shunwen Luo
Shuang Li

Frontiers in Immunology

doi 10.3389/fimmu.2024.1323199

5,065 views
11 citations

Review

Published on 29 Apr 2024

Immunogenic cell death-based cancer vaccines: promising prospect in cancer therapy

in Cancer Immunity and Immunotherapy

Jiandong Wang
Jinyuan Ma
Fangyuan Xie
Fengze Miao
Lei lv
Yueying Huang
Xinyue Zhang
Junxia Yu
Zongguang Tai
Quangang Zhu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1389173

3,791 views
9 citations

Original Research

Published on 29 Apr 2024

Neoadjuvant radiotherapy in ER+, HER2+, and triple-negative -specific breast cancer based humanized tumor mice enhances anti-PD-L1 treatment efficacy

in Cancer Immunity and Immunotherapy

Christina Bruss
Veruschka Albert
Stephan Seitz
Stephanie Blaimer
Kerstin Kellner
Fabian Pohl
Olaf Ortmann
Gero Brockhoff
Anja K. Wege

Frontiers in Immunology

doi 10.3389/fimmu.2024.1355130

2,769 views
2 citations

Original Research

Published on 29 Apr 2024

Comprehensive analysis of human monocyte subsets using full-spectrum flow cytometry and hierarchical marker clustering

in Cancer Immunity and Immunotherapy

Chao Li
Maozhi Xiao
Suxia Geng
Yulian Wang
Lingji Zeng
Peilong Lai
Ying Gong
Xiaomei Chen

Frontiers in Immunology

doi 10.3389/fimmu.2024.1405249

5,301 views
3 citations

Original Research

Published on 29 Apr 2024

An inflammation-related subtype classification for analyzing tumor microenvironment and clinical prognosis in colorectal cancer

in Cancer Immunity and Immunotherapy

Junpeng Pei
Yuye Gao
Aiwen Wu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1369726

3,599 views
6 citations

Correction

Published on 26 Apr 2024

Corrigendum: ITGAL expression in non-small-cell lung cancer tissue and its association with immune infiltrates

in Cancer Immunity and Immunotherapy

Ruihao Zhang
Guangsheng Zhu
Zaishan Li
Zhenzhen Meng
Hua Huang
Chen Ding
Yanan Wang
Chen Chen
Yongwen Li
Hongyu Liu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1415814

1,041 views

Original Research

Published on 26 Apr 2024

DNA methylation regulator-based molecular subtyping and tumor microenvironment characterization in hepatocellular carcinoma

in Cancer Immunity and Immunotherapy

Junsheng Zhao
Zhengtao Liu
Keda Yang
Sijia Shen
Jing Peng

Frontiers in Immunology

doi 10.3389/fimmu.2024.1333923

2,466 views
2 citations